ArticleJournal of translational medicine2025

Ginsenoside Rh2 as a novel PIN1 inhibitor disrupting the cancer stem cell-like phenotype in non-small cell lung cancer.

Xiyu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.